JJ carves itself up at a discount

NEW YORK, April 24 (Reuters Breakingviews) – Johnson & Johnson (JNJ.N) is paying a price to dismember itself. The $422 billion healthcare giant is floating part of its consumer business, named Kenvue, which sells brands ranging from Listerine to Tylenol. It’s hoping to raise $3.5 billion or more, at a…Read More